AbVax enrols first trial participant

Last week, the first participant of the AbVax study was enrolled.

The clinical team, led by Dr Paola Cicconi, administered the study interventions at the Centre for Clinical Vaccinology and Tropical Medicine (CCVTM) at Oxford.

This is an exciting step in the progress of the trial, and we will continue to update you as the trial progresses.